Description: Progyny, Inc. is a medical device company, which engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools. Its services include egg freezing, IVF treatment, surrogacy, podcast, adoption, and Eeva Test. The company was founded on April 03, 2008 and is headquartered in New York, NY.
Home Page: www.progyny.com
PGNY Technical Analysis
1359 Broadway
New York,
NY
10018
United States
Phone:
212 888 3124
Officers
| Name | Title |
|---|---|
| Mr. David J. Schlanger | Exec. Chairman |
| Mr. Peter Anevski | CEO & Director |
| Mr. Mark S. Livingston | Chief Financial Officer |
| Mr. Michael Sturmer | Pres |
| Mr. James Hart | VP of Investor Relations |
| Ms. Risa Fisher | Exec. VP & Chief Marketing Officer |
| Ms. Cassandra Pratt | Sr. VP of People |
| Ms. Julie Stadlbauer | Exec. VP of Strategic Sales & Partnerships |
| Ms. Arielle Bogorad | Sr. VP of Employer Market Strategy |
| Allison Swartz | Exec. VP & GC |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Providers & Services |
| GIC Sub-Industry: | Health Care Services |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 72.5714 |
| Price-to-Book MRQ: | 8.363 |
| Price-to-Sales TTM: | 4.0555 |
| IPO Date: | 2019-10-25 |
| Fiscal Year End: | December |
| Full Time Employees: | 311 |